Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05602376
What this trial is testing

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

Who this might be right for
HIV InfectionsMenTreatment Adherence
Desmond Tutu HIV Foundation 3,642
Testing effectiveness (Phase 2)Study completedNCT02344017
What this trial is testing

Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 23
Post-approval studies (Phase 4)Study completedNCT01115140
What this trial is testing

Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women

Who this might be right for
PregnancyPolycystic Ovary Syndrome
University Magna Graecia 50
Testing effectiveness (Phase 2)Study completedNCT00250068
What this trial is testing

Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

Who this might be right for
Lung DiseasesCancer
University of New Mexico 8
Testing effectiveness (Phase 2)Study completedNCT03623750
What this trial is testing

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Instituto Oncológico Dr Rosell 23
Not applicableWithdrawnNCT01434550
What this trial is testing

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Tumor
H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT01631318
What this trial is testing

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

Who this might be right for
Liver MetastasesColon Cancer
Stanford University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06161818
What this trial is testing

Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

Who this might be right for
Esophageal CancerAdenocarcinoma of the Esophagus
Erasmus Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT00206518
What this trial is testing

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients

Who this might be right for
Breast Cancer
Mothaffar Rimawi 167
Testing effectiveness (Phase 2)Study completedNCT00014690
What this trial is testing

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AstraZeneca
Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Not applicableStudy completedNCT00903890
What this trial is testing

Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkin DiseaseLymphoma, Non-Hodgkin
University of Rochester 32
Not applicableLooking for participantsNCT05831397
What this trial is testing

Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 35
Not applicableLooking for participantsNCT01247597
What this trial is testing

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Who this might be right for
Pleuropulmonary BlastomaCystic NephromaOvarian Sertoli-Leydig Cell Tumors+2 more
National Cancer Institute (NCI) 1,500
Testing effectiveness (Phase 2)Ended earlyNCT05355597
What this trial is testing

"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"

Who this might be right for
Musculoskeletal DiseasesSoft Tissue Mass
Atlantic Health System 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127110
What this trial is testing

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 68
Testing effectiveness (Phase 2)UnknownNCT04082910
What this trial is testing

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Who this might be right for
Solid TumorHematological Malignancy
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00845910
What this trial is testing

Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 22
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Large-scale testing (Phase 3)Looking for participantsNCT05726110
What this trial is testing

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Next Page